Martin A. Mattingly - Apr 19, 2023 Form 4 Insider Report for Tracon Pharmaceuticals, Inc. (TCON)

Role
Director
Signature
/s/ Scott B. Brown, Attorney-in-Fact
Stock symbol
TCON
Transactions as of
Apr 19, 2023
Transactions value $
$0
Form type
4
Date filed
4/21/2023, 08:44 PM
Previous filing
Jun 16, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TCON Director Stock Option (Right to Buy) Award $0 +18K $0.00 18K Apr 19, 2023 Common Stock 18K $1.82 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option shall vest and become exercisable on the earlier of the first anniversary of the grant date set forth in column 3 above or the date of the next annual meeting of the Company's stockholders, subject to the optionee's Continuous Service (as defined in the Company's 2015 Equity Incentive Plan (the "Plan")) and accelerated on the closing of a Change of Control (as defined in the Plan).